by Michael Fenimore | Sep 2, 2021 | Uncategorized
Improving Management of Advanced Non-Melanoma Skin Cancer is a comprehensive, evidence-based curriculum about the challenges in identifying patients at high risk for mBCC and la/mCSCC, screening methods and staging of these patients, and the new and emerging therapies...
by Michael Fenimore | Aug 30, 2021 | Oncology
This CE initiative will offer a roughly 4-week digital curriculum to interprofessional learners. The goal of the initiative is to establish meaningful, small group interactions between clinicians involved in the care of patients with early stage NSCLC that will,...
by Michael Fenimore | Jun 30, 2021 | Uncategorized
The goal of this dynamic curriculum is to reduce individual and systemic barriers to actively address disparities in the delivery of cancer care impacting outcomes for black men and women facing cancer.
by Michael Fenimore | Jun 17, 2021 | Uncategorized
Pulmonary Arterial Hypertension (PAH) is a progressive disease and is associated with poor clinical outcomes. Data from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) has shown that the diagnosis of PAH is often missed or delayed with the...
by Michael Fenimore | May 28, 2021 | Uncategorized
Patients with Fabry disease (FD) have a significantly shorter life expectancy compared to the general population, often due to cardiac or renal complications of this rare disease. There are only 2 approved therapies for FD—enzyme replacement therapy and chaperone...
